TB surveillance and surveys
WHO training workshop for consultants
Geneva, Switzerland, 24-27 May 2011
Presentations
Day 1 - 24 May
-
Katherine Floyd: WHO's work on TB care and control with particular attention to TB monitoring and evaluation: an overview
pdf, 1.33Mb -
Philippe Glaziou: Methods used for the estimation of TB disease burden and related efforts to strengthen TB surveillance
pdf, 4.43Mb -
Matteo Zignol: The Global Project on anti-TB drug resistance surveillance: background, objectives, achievements, challenges, next steps
pdf, 1.07Mb -
Ikushi Onozaki: The what, why, where and when of nationwide TB prevalence surveys, and progress to date in global focus countries
pdf, 2.99Mb -
Babis Sismanidis: The Lime Book: an overview of WHO recommendations for the design, implementation and analysis of prevalence surveys
pdf, 499kb
Day 2 - 25 May
-
Babis Sismanidis: Sampling design, with particular attention to sample size calculations and selection of clusters
pdf, 140kb -
Ikushi Onozaki: Chest X-ray: requirements, options, recommendations
pdf, 6.62Mb -
Chris Gilpin: Laboratory: requirements, methods, capacity
pdf, 1.02Mb -
Ikushi Onozaki: Survey organization and cluster operations: census, screening, sputum collection, follow-up
pdf, 9.50Mb -
Babis Sismanidis: Document flow and data management
pdf, 630kb
Day 3 - 26 May
-
Wayne van Gemert: Surveillance of resistance to anti-TB drugs: what is it and how does WHO recommend it should be done?
pdf, 1.37Mb -
Dennis Falzon: Indicators for MDR-TB detection and outcomes
pdf, 1.31Mb -
Matteo Zignol: Sampling design and sample size calculations in drug resistance surveys
pdf, 122kb -
Matteo Zignol: Cluster selection in drug resistance surveys
pdf, 124kb -
Dennis Falzon: Document flow and data management
pdf, 2.67Mb -
Chris Gilpin: Laboratory requirements in drug resistance surveys and the role of the Supranational Reference Laboratory Network (SRLN)
pdf, 1.81Mb -
Wayne van Gemert: Putting everything together: protocol development, budget and protocol checklist
pdf, 834kb
Day 4 - 27 May
Persons interested in obtaining a copy of the exercises carried out should contact tbimpactmeasurement@who.int
- Practical exercise 1: Assessment of surveillance data and systems
- Practical exercise 2: Country scenarios: assessing the relevance and feasibility of a survey, defining objectives and indicators
- Practical exercise 3: Country scenarios: sampling design and sample size calculation
- Practical exercise 4: Protocol review using protocol checklist
- Practical exercise 5: Sample size calculations using country case studies
- Practical exercise 6: Cluster selection using country case studies
- Practical exercise 7: Protocol review using protocol checklist
- Practical exercise 8: Analysis of a drug resistance survey: accounting for clustering
- Practical exercise 9: Analysis of a drug resistance survey: accounting for missing data